Heparinized Pbs Wash
Heparinized Pbs Wash - Related Videos
02:21
Purification of Viral Integrase Using Heparin Affinity Chromatography
0 Views •
2026
Source: Lopez Jr., M. et al. Detection and Removal of Nuclease Contamination During Purification of Recombinant Prototype Foamy Virus Integrase. J. Vis. Exp. (2017)This video demonstrates the procedure for purifying viral integrase from bacterial nuclease contamination using heparin Sepharose column chromatography followed by SDS-PAGE analysis to confirm protein purity.
10:41
Using a GFP-tagged TMEM184A Construct for Confirmation of Heparin Receptor Identity
0 Views •
Cited by 2 •
2017
A construct encoding TMEM184A with a GFP tag at the carboxy-terminus designed for eukaryotic expression, was employed in assays designed to confirm the identification of TMEM184A as a heparin receptor in vascular cells.
12:27
Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery
0 Views •
Cited by 2 •
2016
Self-assembled polyelectrolyte complexes (PEC) fabricated from heparin and protamine were deposited on alginate beads to entrap and regulate the release of osteogenic growth factors. This delivery strategy enables a 20-fold reduction of BMP-2 dose in spinal fusion applications. This article illustrates the benefits and fabrication of PECs.
00:52
Washing, Drying, and Ignition of Precipitates
0 Views •
2024
After filtration, the precipitate is washed to remove coprecipitated impurities and any remaining mother liquor. Colloidal precipitates, such as silver chloride, are washed with an electrolyte (such as dilute nitric acid) to prevent the peptization of the precipitate. In the case of slightly soluble precipitates, the wash solution contains a common ion to reduce solubility. Lead sulfate, which is slightly soluble in water, is washed with dilute sulfuric acid. Similarly, wash solutions may be...
01:30
Anticoagulant Drugs: Low-Molecular-Weight Heparins
0 Views •
2024
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
FAQs
Heparin limits coagulation by binding antithrombin, which suppresses thrombin and factor Xa activity. This reduces fibrin formation while the sample is being handled. The practical consequence is fewer clot-related losses during processing, especially when blood, tumor-associated cells, or other hematologic specimens must remain recoverable for subsequent analysis.
PBS and heparin contribute different protections during a wash. PBS provides an isotonic, near-neutral environment that helps reduce osmotic stress, whereas heparin addresses coagulation by limiting thrombin and factor Xa activity through antithrombin. Combining them supports sample handling without relying on anticoagulation alone to control the washing environment.
Preventing fibrin formation can be important when processing specimens that contain blood or hematologic material. Clot-related loss may reduce the cells available for analysis; limiting clot formation helps maintain recovery during handling. In cancer research, this is relevant to tumor-associated cell preparations and other specimens whose cellular content must be examined.
A basic use pattern is to rinse the biological sample with the solution during processing, using the wash to remove residual contaminants while reducing coagulation-related loss. The provided context specifically supports blood, tumor-associated cells, and other hematologic specimens. It does not specify a universal volume, duration, temperature, or number of washes, so those details are not established here.
The wash is particularly relevant when specimens combine tumor-associated cellular material with blood-related components. Its value lies in addressing two handling challenges at once: reducing residual contaminants and limiting coagulation. That combination can support more consistent recovery of cells for later characterization, rather than restricting the method to a single cancer research assay.
After the rinse, researchers can direct the recovered material to flow cytometry, immunostaining, or molecular assays. These approaches provide complementary ways to analyze the specimen, so the wash functions as a preparation step rather than an endpoint. By reducing residual contaminants and clot-related sample loss, it supports the handling requirements of these downstream measurements.